Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 398 (LINC00398, also known as LINC00545) is a member of the long intergenic non-coding RNA (lincRNA) family, which are RNA molecules longer than 200 nucleotides located in genome regions that do not overlap with protein-coding genes. LincRNAs are broadly involved in the regulation of gene expression, often acting through modulation of chromatin structure, transcription, or RNA processing; however, the precise function of LINC00398 itself has not been clearly characterized in the available literature. No evidence exists to suggest that LINC00398 functions as a conventional therapeutic target such as a receptor, enzyme, transporter, or similar class. There are no known drug interactions, biomarker roles, or established disease associations specific to LINC00398 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 398 (LINC00398).